Login to Your Account



NeuroVive Picks Up Biotica Polyketide Assets

By Cormac Sheridan
Staff Writer

Monday, March 11, 2013
NeuroVive Pharmaceutical AB extended its drug pipeline by picking up a series of polyketide-based preclinical cyclophilin inhibitors from Biotica Technology Ltd., a UK pioneer of polyketide engineering, which is currently in administration.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription